A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa. Full Text
BMC Infectious Diseases, 11/22/2011
Naesens R et al. – Aerosolized colistin could be beneficial as adjunctive treatment for the management of pneumonia due to multidrug–resistant (MDR) P. aeruginosa.